Dicerna

After putting aside a bitter legal feud, Alnylam and Dicerna chiefs make nice with an RNAi collaboration
After putting aside a bitter legal feud, Alnylam and Dicerna chiefs make nice with an RNAi collaboration
Endpoints
Alnylam
Dicerna
John Maraganore
Douglas Fambrough
RNAi
Merck
Flag link:
Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform
Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform
Endpoints
Dicerna
Novo Nordisk
liver disease
RNAi
Flag link:
Eli Lilly makes bet on gene-silencing drug firm Dicerna
Eli Lilly makes bet on gene-silencing drug firm Dicerna
Yahoo/Reuters
Eli Lilly
Dicerna
gene silencing
Flag link:
Biotech companies Alnylam, Dicerna settle trade secrets case
Biotech companies Alnylam, Dicerna settle trade secrets case
Reuters
Alnylam
Dicerna
trade secrets
gene silencing
Flag link:
Dicerna and Boehringer partner on RNAi treatment for NASH
Dicerna and Boehringer partner on RNAi treatment for NASH
Endpoints
Dicerna
Boehringer Ingelheim
NASH
RNAi
Flag link:
8 Biotech Stocks Under $10 Making Big Moves Higher
8 Biotech Stocks Under $10 Making Big Moves Higher
TheStreet.com
Dicerna
Novadaq Technologies
Idera Pharmaceuticals
Versartis
ProNai
Immunogen
Medgenic
Inotek
Flag link:
Biotech Boomlet Set To Smash IPO Record For Two-Week Period
Biotech Boomlet Set To Smash IPO Record For Two-Week Period
Seeking Alpha
biotech
IPOs
Dicerna
Celladon
Flag link: